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Abstract
Mycobacterium africanum consists of Lineages L5 and L6 of the Mycobacterium tuberculosis complex (MTBC) and causes human
tuberculosis in specific regions of Western Africa, but is generally not transmitted in other parts of the world. Since M. africanum
is evolutionarily closely placed between the globally dispersed Mycobacterium tuberculosis and animal-adapted MTBC-members,
these lineages provide valuable insight into M. tuberculosis evolution. Here, we have collected 15 M. africanum L5 strains
isolated in France over 4 decades. Illumina sequencing and phylogenomic analysis revealed a previously underappreciated
diversity within L5, which consists of distinct sublineages. L5 strains caused relatively high levels of extrapulmonary tuberculosis
and included multi- and extensively drug-resistant isolates, especially in the newly defined sublineage L5.2. The specific L5
sublineages also exhibit distinct phenotypic characteristics related to in vitro growth, protein secretion and in vivo immuno-
genicity. In particular, we identified a PE_PGRS and PPE-MPTR secretion defect specific for sublineage L5.2, which was inde-
pendent of PPE38. Furthermore, L5 isolates were able to efficiently secrete and induce immune responses against ESX-1
substrates contrary to previous predictions. These phenotypes of Type VII protein secretion and immunogenicity provide valuable
information to better link genome sequences to phenotypic traits and thereby understand the evolution of the MTBC.
Key words: Mycobacterium africanum, Lineage 5, Tuberculosis, PPE38, PhoPR, Antibiotic resistance.
Introduction
Tuberculosis remains the most deadly infectious disease of
humankind (WHO 2017). Mycobacterium tuberculosis is the
main causative agent of human tuberculosis, but closely
related species of the M. tuberculosis complex (MTBC), such
as Mycobacterium bovis, are able to infect a wide range of
domestic and wild animals (Malone and Gordon 2017). The
majority of the more than 10 million annual human cases are
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caused by M. tuberculosis strains of Lineages (L)1–4,
but besides M. tuberculosis, the so-called Mycobacterium
africanum strains are also known as causative agents of hu-
man tuberculosis in West Africa. M. africanum strains were
first described in 1968 from tuberculosis patients in Senegal
(Castets et al. 1968), and based on phenotypic differentiation
criteria these strains showed characteristics that were inter-
mediate between M. tuberculosis and M. bovis (David et al.
1978; Thorel 1980). However, the use of primarily phenotypic
criteria resulted in the situation that the exact phylogenomic
position of M. africanum strains remained rather vague, as
within the strains defined as M. africanum, some groups of
strains also closely resembled M. tuberculosis (Haas et al.
1997; Frothingham et al. 1999; Mostowy et al. 2002;
Niemann et al. 2002; Sola et al. 2003). Finally, it was the
use of comparative genomics, which allowed a clearer phylo-
genic positioning of M. africanum strains to be established
(Brosch et al. 2002; Gagneux et al. 2006). According to this
classification, M. africanum strains share a common ancestor
that has undergone deletion of the region of difference
RD9 and are subdivided into Lineages L5 (also known as
M. africanum 1) and L6 (also known as M. africanum 2)
(Brosch et al. 2002; Gagneux et al. 2006). In addition to the
absence of region RD9, M. africanum L6 strains also lack RD7,
RD8, and RD10, similar to the animal adapted strains of the
MTBC. These latter three regions have been retained in the
genomes of M. africanum L5 strains, indicating that L5 strains
have branched from the common RD9-deleted ancestor be-
fore the deletion of regions RD7, RD8, and RD10 occurred. This
grouping was confirmed by single nucleotide polymorphism
(SNP) analyses of whole genome sequences from a few se-
lected strains, which suggest thatM. africanum L5 strains show
about 2,100 SNPs (filtered) in their genomes relative to the M.
tuberculosis H37Rv reference sequence (Comas et al. 2010;
Coscolla et al. 2013). Mycobacterium africanum L5 strains
thus occupy an ancestral and particularly interesting place in
the phylogeny of the tubercle bacilli, which encouraged us to
investigate the M. africanum L5 strains in more detail.
Up to now, only a small number of L5 strain genomes have
been analyzed and published (Comas et al. 2010; Winglee
et al. 2016; Zhu et al. 2016) and phenotypic traits of these
strains that might affect their diagnosis, transmission, or viru-
lence characteristics are rarely investigated (de Jong et al.
2010; Gehre, Otu et al. 2013). M. africanum L5 strains are
endemic in a number of countries around the Gulf of Guinea,
such as Cameroon, Nigeria, Benin, Ghana, Ivory coast, and
Sierra Leone, where they cause between 6% and 39% of all
tuberculosis cases (de Jong et al. 2010). Some rare M. africa-
num L5 cases are recorded outside of this region, which are in
the large majority associated with patients that were born in
this region (de Jong et al. 2010; Sharma et al. 2016). Thus, the
geographic restriction of M. africanum is an interesting char-
acteristic, investigation of which may lead to novel insights
into the global dispersal of related MTBC members, such as
M. tuberculosis sensu stricto and the animal adapted M. bovis
(Brites and Gagneux 2015; Stucki et al. 2016).
In this study, we have investigated a panel of 15 L5 strains
comprising a large part of the collection of both the current
and former French national reference centers for tuberculosis
during the last four decades. We sequenced the genomes of
these isolates and performed phylogenomic analysis and com-
parative genomics. The obtained data were combined with
phenotypic assessment of drug susceptibility, protein secre-
tion, immunogenicity, and growth characteristics and allow
identification of genomic sublineages with a surprising level of
genomic and phenotypic variation.
Materials and Methods
Growth Conditions
All newly analyzed isolates of M. africanum (supplementary
table 1, Supplementary Material online) were isolated in differ-
ent locations in France and subsequently sent to the national
reference laboratory. Strains were grown on solid culture me-
dia of Lo¨wenstein–Jensen (Beckton–Dickinson) and Coletsos.
Cultivation of all isolates (supplementary table 2,
Supplementary Material online) was performed on 7H11 solid
medium with OADC supplement (Difco), or in liquid 7H9 me-
dium supplemented with ADC (Difco), 0.05% Tween 80, and
0.2% w/v pyruvate (Keating et al. 2005). Kanamycin was
added at a concentration of 25 mg/l where appropriate.
Plasmids and Primers
All primers that were used for initial antibiotic resistance test-
ing have been described (Brossier et al. 2017). Other primers
used in previous studies (Brosch et al. 2002; Abdallah et al.
2006; McEvoy et al. 2009; Otchere et al. 2016) can be found
in supplementary table 4, Supplementary Material online. The
pMV::mt2419-22 (ppe38-71) plasmid was previously pub-
lished (Ates, Dippenaar et al. 2018).
Phenotypic Drug Susceptibility Testing
In vitro drug susceptibility testing was performed on
Lo¨wenstein–Jensen medium with the standard proportions
method, as previously described (Canetti et al. 1963), with
the following concentrations: 40 mg/l rifampicin, 0.2 (Low)
and 1 (High) mg/l isoniazid, 2 mg/l ethambutol, 4 mg/l
streptomycin, 2 mg/l ofloxacin, 20 mg/l amikacin, 30 mg/l
kanamycin, 40 mg/l capreomycin, 40 mg/l ethionamide,
30 mg/l cycloserin, 1.0 mg/l para-aminosalicylic acid, 1.0 mg/l
linezolid (Barrera et al. 2008; WHO 2014).
DNA Sequencing of Genes Associated with Drug
Resistance
Genomic DNA, used for genomic susceptibility testing, was
isolated from bacteria grown on Lo¨wenstein–Jensen medium.
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A loop of culture was suspended in water (500ml) and heated
at 95 C for 15 min. The DNA used for polymerase chain
reaction (PCR) amplification was obtained by heat shock ex-
traction (1 min at 95 C and 1 min on ice, repeated five times).
Five microliters were submitted to PCR amplification using the
oligonucleotide primers described (Brossier et al. 2017). After
amplification, unincorporated nucleotides and primers were
removed by filtration with Microcon 100 microconcentrators
(Amicon, Inc., Beverly, MA), and the amplicons were se-
quenced by using the BigDye Terminator cycle sequencing-
ready kit according to the manufacturer’s instructions.
Determination of Phylogenomic Lineage
The phylogenomic lineages of our MTBC isolates were
determined by using the mycobacterial interspersed repet-
itive-unit–variable-number tandem-repeat (MIRU-VNTR)
molecular typing method for all NRC-isolates. Standard
24-locus-based MIRU-VNTR typing was performed as de-
scribed previously (Supply et al. 2006), with the MIRU-
VNTR typing kit from GenoScreen. The amplified fragments
were analyzed on a 16-capillary Applied Biosystems 3130
genetic analyzer. To determine the lineages of the isolates,
the 24 numerical values generated by MIRU-VNTR analysis
were compared with those in the MIRU-VNTRplus database
(http://www.miru-vntrplus.org/).
DNA Isolation for Genome Sequencing
Mycobacterial genomic DNA was isolated by bead-beating,
boiling, and ethanol precipitation as described previously
(Howard 2006; Pawlik et al. 2013). Libraries were prepared
from the mycobacterial DNA using the Nextera DNA Library
Preparation Kit (Illumina, San Diego, CA) following the man-
ufacturer’s recommendations for all strains except for strain
01, 72, 65, 66, 68, and 77, which were prepared with the
NextFlex PCR-Free Library preparation. Specific indexes were
introduced in both library adapters (double indexing) to allow
multiplexed paired-end sequencing. Quality and quantity for
each library were checked with the Fragment Analyzer
(Advanced Analytical Technologies, Inc., Ames, IA). A total
of 108 bp paired-end runs were performed on an Illumina
HiSeq 2500 platform for all previously published strains (sup-
plementary table 2, Supplementary Material online) and
newly described isolates were sequenced by an Illumina
MiSeq using a paired-end (2 255 bp) approach.
Preprocessing, Alignment, and Variant Detection
Illumina paired-end sequencing data for all isolates pub-
lished in the current study (N¼ 16) and 49 genomes, rep-
resentative of the members of the MTBC, published
previously or available in public databases (supplementary
table 3, Supplementary Material online) were analyzed with
a pipeline composed of open source software as described
previously (Dippenaar et al. 2017). Briefly, trimming of
adapters and low-quality bases (Phred quality score of less
than 20) using a sliding window approach, and filtering for
a minimum read length of 36 was done with Trimmomatic
(Bolger et al. 2014). Reads were aligned to theM. tuberculosis
H37Rv (Genbank: AL123456) and M. tuberculosis CDC1551
genome (Genbank: AE000516) using three different align-
ment algorithms: The Burrows–Wheeler Alignment (BWA)
Tool (Li and Durbin 2009), Novoalign, and SMALT (Ponstingl
and Ning 2010). For all sequenced isolates, over 97% of the
reference genome was covered by at least one read and an
average depth of coverage of 189 (minimum 89, maximum
328) was achieved, when considering the average depth of
coverage for each isolate aligned to M. tuberculosis H37Rv
with BWA, Novoalign and SMALT. The alignment files were
subjected to local realignment and deduplication using the
Genome Analysis Toolkit (GATK) (McKenna et al. 2010) and
Picard (Winglee et al. 2016). Variants [SNPs and insertion/
deletions (indels)] in coding and noncoding regions were iden-
tified from each alignment file using GATK (McKenna et al.
2010), and the variants identified in all three alignments were
used for further analysis. Variants were annotated using an-
notation data from TubercuList (Lew et al. 2011), and drug
resistance was inferred from a drug resistance mutation li-
brary (Coll et al. 2015). SpolPred and SpoTyping were used
to predict the spoligotype patterns of all the sequenced M.
africanum isolates (Coll et al. 2012; Xia et al. 2016). Genotypic
drug resistance prediction based on WGS was done using
TBprofiler (Coll et al. 2015).
Phylogenomic Analysis
The raw sequencing data generated for the purpose of this
study and 49 selected mycobacterial genomes published pre-
viously or available in public databases (Comas et al. 2010;
Biek et al. 2012; Blouin et al. 2012, 2014; Coscolla et al. 2013;
Bradley et al. 2015; Alexander et al. 2016; Winglee et al.
2016; Zhu et al. 2016), depicted in supplementary table 3,
Supplementary Material online, were analyzed. Variants in
repetitive regions, such as pe/ppe and pe_pgrs gene families,
were excluded for phylogenomic analysis and only variants
supported by at least 90% of reads at a given position with
a minimum depth coverage of ten reads were considered.
Concatenated sequences containing high-confidence variable
sites (coding and noncoding SNPs) with respect to the M.
tuberculosis H37Rv reference genome were used to infer
the phylogenomic relationship between the various strains
analyzed as previously described (Dippenaar et al. 2017).
The general time reversal model of nucleotide substitution
was applied to generate a maximum likelihood phylogeny
of the isolates included in this analysis with Randomized
Axelerated Maximum Likelihood (RaxML) with 1,000 boot-
strap pseudoreplicates (Stamatakis 2015). Positions contain-
ing gaps or missing data were not considered for the analysis.
Ates et al. GBE
1860 Genome Biol. Evol. 10(8):1858–1874 doi:10.1093/gbe/evy145 Advance Access publication July 13, 2018
D
ow
nloaded from
 https://academ
ic.oup.com
/gbe/article-abstract/10/8/1858/5053700 by U
niv of Stellenbosch user on 27 Septem
ber 2019
De Novo Assembly and Annotation
De novo assembly of the sequenced M. africanum isolates
was done with SPAdes using one Illumina paired-end library
for each isolate (Bankevich et al. 2012). The M. tuberculosis
CDC1551 genome annotation was transferred to the assem-
bled scaffolds of each isolate using RATT (Otto et al. 2011).
Contigs containing the regions of interest were further stud-
ied in Artemis (Rutherford et al. 2000), Artemis comparison
tool (Carver et al. 2005) and/or Integrative genomics viewer
(Robinson et al. 2011).
Growth Assessment
Growth in liquid culture was performed as previously de-
scribed (Le Chevalier et al. 2015). In short, precultures were
grown until exponential phase, washed one time in fresh
growth medium and inoculated in 5 ml 7H9 containing
ADC, Pyruvate, and Tween 80 in 25 ml glass tube. OD600
was measured at indicated time-points. Regular aeriation of
the tubes was undertaken by opening tubes under sterile
conditions to ensure the presence of oxygen for optimal
growth. The experiment was performed in biological tripli-
cates of technical duplicates. Please note that OD600 was
only measured during weekdays and therefore not every
data point represents three biological replicates.
Growth on solid medium was assessed by diluting 200ml of
the liquid culture at Day 1 of the growth curve in 10-fold
dilutions. A 20ml of each dilution was spotted on
7H11 þ OADC solid growth medium and incubated for
18 days, after which colonies were counted and photo-
graphed, colonies were recounted 7 days later.
Secretion Analysis
Secretion analysis was performed broadly as described previ-
ously, with some modifications (Houben et al. 2012; Ates
et al. 2015). Strains were precultured as described above until
all strains reached the exponential phase (OD600 between 0.6
and 1.2), after which they were washed with 7H9 medium
without ADC, but supplemented with 0.2% dextrose, 0.2%
pyruvate, and 0.025% Tween 80. Washed cells were inocu-
lated in the same medium at a starting OD600 of 0.5 for M.
africanum strains or 0.4 OD600 for M. tuberculosis H37Rv and
were incubated at 37 C under shaking conditions over two
nights. Cultures were centrifuged and supernatants were fil-
tered (0.22lm filters, Millipore) and precipitated with
Trichloroacetic acid (TCA). Cells were washed with PBS and
suspended in solubilization/denaturation buffer, heat inacti-
vated for 2–4 h at 80 C, sonicated to disrupt cells and boiled
for 10 min at 95 C.
SDS-PAGE gels were loaded with an equivalent of 0.225
OD-units for whole cell lysates and 0.6 OD-units for culture
filtrates. Western blots were stained with antibodies: Anti-
PGRS 7C4.1F7 (antibody-producing clone kind gift by MJ
Brennan, Aeras, Rockville, MD) (Abdallah et al. 2009), anti-
SigA (Kind gift from Ida Rosenkrands, Statens Serum Institut,
Copenhagen, Denmark), anti-GroEL2 antibody CS-44 (Kind
gift from J. Belisle, Colorado State University, Fort Collins, CO)
Rabbit polyclonal anti-EsxN (rMTb9.9A) (Alderson et al. 2000),
and monoclonal ESAT-6 hyb 76-8 (Harboe et al. 1998).
Immunogenicity of M. africanum Sublineages
Six-week-old female C57BL/6 x CBA F1 (H-2b/k) mice (n¼ 2
mice/group) received subcutaneous injection of 1 106 CFU/
mouse of diverse M. africanum, or M. tuberculosis H37Rv
strains. Three weeks postimmunization, total splenocytes
were cultured in 96-well flat-bottom plates (TPP, Denmark)
at 5105 cells per well in HL-1 medium (Biowhittaker, Lonza,
France), complemented with 2 mM GlutaMax (Invitrogen, Life
Technologies, France), 5105M b-mercaptoethanol,
100 U/ml penicillin, and 100lg/ml streptomycin (Sigma-
Aldrich, France) in the presence of 10lg/ml of synthetic pep-
tides bearing MHC-II or -I-restricted mycobacterial epitopes.
Concanavalin A and PPD were used as positive controls for cell
viabilities and successful immunization, respectively, while
MalE: 100–114 peptide was used as negative control as pre-
viously described (Sayes et al. 2016; Ates, Sayes et al. 2018).
After 3 days of incubation at 37 C and 5% CO2, IFN-c
produced in the culture supernatant was quantified by sand-
wich ELISA (clone AN-18 for coating and clone R46A2 for
detection, BD Biosciences, San Jose, CA). Data were analyzed
by using Prism software (GraphPad Software, La Jolla, CA).
Results
Strain Isolation and Clinical Characterization
The French National Reference Centre for Mycobacteria (NRC
MyRMA, http://cnrmyctb.free.fr) routinely receives approxi-
mately 1,000 clinical samples and mycobacterial strains per
year that are isolated in France. The isolated MTBC strains are
subjected to phenotypic and genotypic drug susceptibility
testing (WHO 2014). The phylogenetic diversity is evaluated
by determining mycobacterial interspersed repetitive unit
variable-number tandem repeat (MIRU-VNTR) codes of the
strains (Supply et al. 2006). In this capacity, a total of seven
M. africanum L5 strains were isolated between 2007 and 2015
(supplementary table 1, Supplementary Material online).
Although strains were isolated from patients living in dif-
ferent locations in France, the places of birth of these patients
are located in Western or Central Africa in all cases where this
information was available (table 1). Average patient age was
41.7 years [standard deviation (SD) ¼ 0.7]. Three patients
were reported as HIV positive (average age 32.7, SD ¼ 6.1)
and three patients were HIV negative (average age 45.7,
SD¼ 6.5), while the HIV status of one patient was unknown.
Bacterial isolates were derived from different patient samples
and remarkably, were isolated from extrapulmonary sites in
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five out of the seven cases, which was not strictly dependent
on HIV status (table 1). The high proportion of extrapulmonary
tuberculosis caused by these strains suggests that L5 strains
might show a different ability to cause pulmonary disease than
M. tuberculosis senso stricto strains. The low number of
M. africanum L5 strains isolated over 9 years and the lack of
detected transmission episodes are in agreement with an ab-
sence of transmission of M. africanum L5 within France.
Phenotypic and genotypic drug susceptibility testing classified
isolates NRC6 and NRC7 as multidrug resistant (MDR), because
they were resistant to both isoniazid and rifampicin. In addi-
tion, NRC7 was classified as pre-extensively drug-resistant (pre-
XDR: MDR also resistant to the injectable aminoglycoside
kanamycin). Three strains were susceptible to first-line drugs
(table 2). Corresponding to the described association between
HIV and drug resistance described for M. tuberculosis sensu
stricto (Mesfin et al. 2014), the pan-susceptible strains were all
isolated from HIV negative patients. The patient infected with
NRC3 was previously treated for tuberculosis, while no previ-
ous treatment information was available for the patient
infected with NRC6. In contrast, the five other patients were
not documented to have previously received tuberculosis treat-
ment, suggesting transmission of drug-resistant isolates in-
stead of de novo in-patient acquisition of drug resistance.
Phylogeny of M. africanum Lineage 5 Reveals Distinct
Sublineages
To gain more insight into the diversity of M. africanum L5,
genomic DNA was isolated from all L5 strains described
above. This panel of strains was supplemented with eight
additional L5 and two L6 strains from the former National
Reference Laboratory for Mycobacteria (at the Institut
Pasteur, Paris, France). This second collection of strains was
isolated between 1965 and 1998 and these strains were pre-
viously genotyped by spoligotyping to belong to their respec-
tive lineages (Viana-Niero et al. 2001; Brudey et al. 2004)
(supplementary table 2, Supplementary Material online).
Illumina sequencing of the genomic DNA resulted in an
average depth of coverage of between 84- and 328-fold
and between 97% and 99% of reads were mapped to the
Lineage 4 reference genome H37Rv (supplementary file 1,
sheet 1, Supplementary Material online). Based on these
data, a comprehensive table of SNPs and insertions/deletions
(indels) was constructed to compare isolates (supplementary
file 2, sheet 2, Supplementary Material online). More stringent
filtering criteria (Materials and Methods) were used to define
a panel of SNPs with high confidence that was used to define
the phylogenomic relationship between the sequenced M.
africanum isolates and a panel of previously published
genome-sequences (supplementary table 3, Supplementary
Material online) by maximum likelihood analysis. The con-
structed bootstrap consensus tree fully supported the previous
classification of all strains to L5, or L6 (fig. 1A). L5 strains were
clearly separated from L6 and were more distantly related to
the animal adapted strains of the MTBC, consistent with pre-
vious reports (Brosch et al. 2002; Hershberg et al. 2008).
Strikingly, a comparison of only the L5 strains among each
other, revealed at least two separated subgroups in the phy-
logeny, which we propose to name M. africanum sublineage
5.1 and 5.2, respectively (figs. 1A and 1B).
The identified L5 sublineages correspond well to the clas-
sification proposed by Brudey et al., which was based on ex-
tended spoligotyping profiles, obtained from a selection of
these strains (supplementary table 2, Supplementary
Material online) (Brudey et al. 2004). Sublineage 5.1 (L5.1)
corresponds to the previously identified Subgroup A2 de-
scribed by Viana-Niero et al. (2001) or Subgroup A2-1 de-
scribed by Brudey et al. (2004). A second cluster of seven
strains from our collection, which we propose to name
L5.2, corresponds to the previously described Subtypes A2-3
(Brudey et al. 2004). Two strains (69 and NRC1) diverged close
to the root of L5, in between the two larger sublineages.
Strain 69 was previously classified as subtype A2-2 (Brudey
et al. 2004) and based on phenotypic characteristics these
isolates could be seen as an independent sublineage.
However, it should be noted that we were not able to identify
sublineage-specific polymorphisms shared between these
two strains and the phylogenomic distance from each other
and the other sublineages suggest that they are orphan
Table 1
Patient Characteristics Corresponding to Newly Isolated Strains
Strain name Gender Age Country of birth Patient material Isolated in location, year HIV-status Ziehl-Neelsen
NRC1 Female 39 Benin Bronchial aspirate Besanc¸on, 2007 Negative Negative
NRC2 Male 38 Cameroon Lymph node Paris, 2008 Positive Negative
NRC3 Female 26 Unknown Blood Lyon, 2008 Positive Negative
NRC4 Male 52 Unknown Vertebral biopsy Caen, 2008 Negative Positive
NRC5 Male 46 Ivory Coast Lymph node Poitiers, 2010 Negative Positive
NRC6 Male 57 DR Congo Lymph node Angers, 2011 Unknown Unknown
NRC7 Female 34 DR Congo Sputum Lille, 2015 Positive Negative
Information is reported as provided by physicians sending the isolates to the NRC.
DR, Democratic Republic of
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representatives of independent sublineages. Notably, all pre-
viously published L5 genomes, clustered inside L5.1 (Comas
et al. 2010; Winglee et al. 2016; Zhu et al. 2016), suggesting
that the genomic diversity within L5 may have been under-
estimated in previous whole-genome sequencing studies
(Comas et al. 2010; Copin et al. 2014).
Together, these results largely confirm the previous classi-
fication of these strains based on spoligotyping and PCR-
based methods, but show a markedly different phylogenomic
relationship between the isolates than previously suggested
(Viana-Niero et al. 2001; Brudey et al. 2004). Our analysis
suggests that the orphan representatives NRC1 and isolate
69 diverged from the most-recent common ancestor at a
similar timescale as the sublineages L5.1 and L5.2 and these
may represent independent sublineages, although more in-
sight might be obtained as more sequences become available.
Previously Proposed Phylogenomic Markers Underestimate
L5 Diversity
Different molecular methods have been previously proposed to
distinguish M. africanum L5 from other MTBC lineages. Since
the phylogenomic analysis revealed that all published L5
genomes clustered with the L5.1 strains, we investigated
whether these genetic methods were able to classify all L5
strains accordingly. Vasconcellos et al. (2010) previously de-
scribed two SNPs that were used to uniquely identify L5 and
L6 strains of M. africanum. Indeed, all L5 strains in our
collection harbored the rv1332G-523->T polymorphism that
was absent from the L6 strains. Conversely, both L6 strains
harbored the nat(rv3566c)C-751->T polymorphism, which was
absent from all L5 strains (fig. 1A; supplementary file 1,
Supplementary Material online). These results confirm these
SNPs as reliable genotyping markers for these lineages.
However, single-SNP analysis carries risks of creating false pos-
itives, compared with the analysis of large sequence polymor-
phisms or regions of difference (RD). PCR-based analysis of RDs
has allowed reliable classification of the different lineages of
the MTBC in a cost- and labor-effective way (Gordon et al.
1999; Brosch et al. 2002; Tsolaki et al. 2004).
Mycobacterium africanum L5 has in this way been defined as
a TbD1-intact lineage having a deletion of the RD9 region,
carrying intact RD7, RD8, RD10, and RD702 loci, whereas M.
africanum L6 and animal adapted strains additionally have de-
leted RD7, RD8, RD10, and RD702 regions (fig. 1A) (Brosch
et al. 2002; Hershberg et al. 2008). We utilized the obtained
Illumina sequence data to catalog these large deletions by map-
ping paired-end reads to the M. tuberculosis H37Rv reference
genome, taking also into account the genome-wide depth of
coverage (supplementary file 3, Supplementary Material online)
and visual inspection of the alignment of suspected deleted
regions (supplementary fig. 1, Supplementary Material online).
The thereby obtained lineage differentiation was found to
be robust for all strains tested (fig. 1; supplementary files 1
and 3, Supplementary Material online). However, it would be
preferable to have a single unique and lineage-specific marker
Table 2
Phenotypic and Genotypic Antibiotic Susceptibility Profiles of Newly Isolated Strains
Genotypic Resistance mutations
Name Previously treated Phenotypic resistance rpoB katG PinhA pncA Other
NRC1 No Susceptible wt wt wt wt
NRC2 No Isoniazid (Low), streptomycin wt wt c15t wt gyrA/gyrB: wt
NRC3 Yes Streptomycin wt wt wt wt gyrA/gyrB: wt
NRC4 No Susceptible wt wt wt wt
NRC5 No Susceptible wt wt wt wt
NRC6 Unknown Isoniazid (High), rifampicin,
ethionamide, streptomycin,
para-aminosalicylic acid
S450(531)L S315T wt wt ethA G124D
ethR: wt
gyrA/gyrB: wt
rrs1400*: wt
embB M306: wt
NRC7 No Isoniazid (High), rifampicin,
pyrazinamide, ethambutol,
ethionamide, streptomycin,
kanamycin, para-aminosalicylic acid
S450(531)L S315T wt S104R embB M306I
ethA: G124D
ethR: wt
gyrA/gyrB: wt
rrs1400*: wt
Genotypic antibiotic susceptibility was tested for ﬁrst-line drugs isoniazid (katG, PinhA, promoter of inhA), rifampicin (rpoB), pyrazinamide (pncA) (Barrera et al. 2008;WHO
2014), by different PCRs and Sanger-sequencing as described previously (Brossier et al. 2017). When an isolate was resistant to any of these antituberculosis drugs, second-line
drugs ethionamide (ethA, ethR); aminoglycosides (*, rrs region 1400, eispromoter), ﬂuoroquinolones (gyrA/gyrB) andpara-aminosalicylic acidwere tested. Genotypic susceptibility
is indicated as “wt” (wild-type), or the resulting amino acid (upper case), or base (lower case) changes. First letter depicts amino acid in reference sequence; second letter depicts
detected amino acid/base; rpoB positions between brackets represent positions in older nomenclature system; Position is depicted as number in subscript. N.P., not performed.
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for L5. The RD711 deletion in genes rv1333-36, was first pro-
posed by Mostowy et al. and is often suggested as such a
specific marker for L5 strains (Mostowy et al. 2004; Gagneux
et al. 2006; de Jong et al. 2010). Strikingly, our mapping and
de novo assembly analyses revealed that this region was in-
deed deleted in all L5.1 strains, but was intact in all other L5
strains (fig. 1A). These results show that RD711 cannot be
used as a universal marker of L5 strains, which was previously
suggested (Huard et al. 2006), although it may still be useful
to define L5.1 strains.
Three other RD described by Mostowy et al. were here
found to be shared between all L5 strains: that is, RD713
affecting rv1977-rv1979c, RD743 affecting rv1992c-1996,
and RD715 affecting rv2479c-rv2480c (supplementary fig.
1, Supplementary Material online). Therefore, we propose
that these RD have the potential to pose as more reliable
Fig. 1—Phylogenomic analysis of sequenced and previously published isolates reveals three sublineages within M. africanum L5. (A) Bootstrap con-
sensus tree based on 32,510 variable positions inferred from 1,000 bootstrap replicates is taken to represent the evolutionary history of the isolates
(Felsenstein 1989). Previously published genomes and associated accession numbers are listed in supplementary table 3, Supplementary Material online.
The phylogenomic analysis was performed with RaxML and is based on variable positions identified with respect toM. tuberculosisH37Rv ( Stamatakis 2006,
2014). Lineages 1, 2, 3, and 4 as well as M. bovis andM. caprae strains are depicted as collapsed branches. A strain of the nonclonal, smooth tubercle bacilli
(Blouin et al. 2014; Boritsch et al. 2014) known as Mycobacterium canettii, was used to establish the root of the tree, but is not depicted. Large sequence
polymorphisms specific for the (sub)lineages are depicted within black boxes. SNPs specific for either L5 or L6 are depicted in brown or green, respectively. (B)
Radial tree of L5 strains depicts the clear separation of L5.1 and L5.2 and the intermediate position of the orphan L5 isolates (light blue). Isolates sequenced in
this study are in bold typeset. Newly proposed sublineages are color coded in the tree as: L5.1 (brown) and L5.2 (Lilac). Scale bars depict SNPs/1,000
base pairs.
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markers specific for L5 isolates. However, the flanking region
of RD713 partially overlaps with that of RD7 and therefore
may fail to produce a PCR product in certain strains (supple-
mentary fig. 1, panel 2, Supplementary Material online)
(Mostowy et al. 2004; Huard et al. 2006; Vasconcellos et al.
2010). To our knowledge RD715 and RD743 have not been
widely used for genotyping of M. africanum and should first
be tested rigorously for specificity, before being implemented
in further studies. This is especially true for RD715, which is
corresponding to an IS6110 element and may therefore be
variable and/or unspecific. Unfortunately, we were unable to
identify any large deletions specific for sublineage 5.2 and
therefore propose that this sublineage is better identified by
analyzing combinations of L5.2-specific SNPs (supplementary
file 2, sheet 3, Supplementary Material online). We did not
identify deletions or SNPs specific for the orphan representa-
tives, and therefore these isolates were not classified as an
independent sublineage.
Bioinformatic Prediction of Drug Resistance is Applicable to
M. africanum L5 and Uncovers a 33-kb Deletion
Responsible for Isoniazid Resistance and a Putative
Association Between L5.2 and Drug Resistance
Genome sequencing is used with increasing frequency in a
clinical setting to predict phenotypic antibiotic resistance of
M. tuberculosis. Development and validation of these meth-
ods are usually based on isolates that are most prevalent in
the local clinical setting. However, it is not clear whether the
same prediction parameters also apply to more distantly
related isolates, such as M. africanum L5 strains. The avail-
ability of phenotypic drug-resistance profiles and whole ge-
nome sequences of the isolated L5 strains, prompted us to
compare the bioinformatic, PCR-based and culture-based
drug-resistance profiles. The predicted drug-resistance pro-
files of first-line antibiotics isoniazid, rifampicin, and pyrazi-
namide fully corresponded to the observed culture-based
antibiotic profiles (table 2; supplementary file 1, sheet 2,
Supplementary Material online). All the L5.1 strains included
in this study were susceptible to all the antituberculosis
drugs tested (table 2; supplementary file 1, sheet 2,
Supplementary Material online). Orphan strain NRC1 iso-
lated in 2007, was also pan-susceptible and orphan isolate
69 harbored a L533P mutation conferring only low level re-
sistance to rifampin. In contrast, four out of the seven L5.2
isolates were resistant to multiple anti-TB drugs (supple-
mentary file 1, sheet 2, Supplementary Material online).
Isolate NRC2 was resistant to isoniazid because of a nucle-
otide substitution c-15t in the inhA promoter. Isolates NRC6
and NRC7 were both MDR (Rifampicin-R plus Isoniazid-R)
and displayed S450(531)L in RpoB and S315T in KatG, which
together represent the most commonly encountered muta-
tions in MDR MTBC clinical isolates. For isolate NRC7, which
is pre-extensively drug-resistant (MDR also resistant to the
injectable aminoglycoside kanamycin), resistance to kana-
mycin was correctly predicted by the mutation in the eis
promoter (g-37t). In addition, NRC7 was also resistant to
pyrazinamide (mutation S103R in PncA) and to ethambutol
(mutation M306I in EmbB). The comparison of the 24 loci-
MIRU-VNTR profiles of the NRC isolates clearly indicates that
NRC6 and NRC7, isolated in 2011 and 2015, respectively,
from 2 patients born in the Democratic Republic of the
Congo, are closely related (supplementary table 1,
Supplementary Material online). They differ only by 1/24
loci, at the level of locus 2163b/QUB11B and are separated
by nineteen high-confidence SNPs (defined as a position
read coverage >10 and a frequency of >90%; supplemen-
tary file 2, Supplementary Material online), suggesting that
the two patients belonged to a chain of transmission of a
clone in circulation during the 2011–2015 period in this
country. However, direct transmission thresholds are usually
set at 5–10 SNPs and these cases are therefore likely sepa-
rated by other cases, which is supported by the finding that
both isolates had unique SNPs (i.e. NRC6: 12 SNPs; NRC7: 7
SNPs). Considering the extended resistance profile of NRC7
compared with NRC6, it is likely that the 2 isolates are ep-
idemiologically linked to a common L5.2 MDR epidemic
clone that has evolved to gain additional resistance to kana-
mycin, pyrazinamide and ethambutol, to yield the pre-XDR
NRC7 strain isolated in 2015. Finally, isolate 77 was
rifampin-resistant with an RpoB N435(516)V mutation.
Interestingly, isolate 77 was also classified as a MDR isolate,
since it was predicted to be resistant to isoniazid due to
deletion of katG. Certain mutations in katG (rv1908) are
known to confer isoniazid resistance, through the role of
KatG as a catalase/peroxidase that transforms the prodrug
isoniazid to its active form (Zhang et al. 1992; Johnsson
et al. 1997). Complete deletion of katG as a mechanism
of isoniazid resistance has been described before, but is
rare and such katG deletion events are commonly associ-
ated with a decreased virulence, as determined in animal
models (Middlebrook and Cohn 1953; Li et al. 1998; Pym
et al. 2002; Tsolaki et al. 2004). However, the ahpC promo-
tor polymorphism at position 48 likely functions as a com-
pensatory mutation for the negative effect of this katG-
deletion (supplementary file 1, sheet 2, Supplementary
Material online). PCR amplification confirmed the absence
of katG in isolate 77 and revealed its presence in all other
isolates tested. Culture-based phenotypic resistance
showed that isolate 77 was indeed highly resistant
(MIC> 1.0mg/ml) to isoniazid, whereas the closely related
isolate 68 was phenotypically susceptible (MIC< 0.2mg/ml).
Closer inspection of read-coverage in the genetic region
containing katG, revealed a very large deletion affecting
genes corresponding to rv1879 to rv1917c (supplementary
fig. 1, panel 2, Supplementary Material online). The deletion
concerns a 33.8 kb genomic region corresponding to posi-
tions 2,129,643 to 2,163,457 in the M. tuberculosis H37Rv
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genome (Cole et al. 1998; Kapopoulou et al. 2011). This is
to our knowledge the largest-known genomic deletion in
the MTBC and includes 38 open reading frames (supple-
mentary file 3, sheets 2 and 16, Supplementary Material
online).
Sublineage-Dependent In Vitro Growth Characteristics
M. africanum is known to exhibit specific in vitro growth
characteristics compared with M. tuberculosis sensu stricto
(Castets et al. 1968; Gehre, Otu et al. 2013). Most notable
are a relatively slow growth, dependence on pyruvate in liquid
media and small colonies on solid media, which can lead to
underdiagnosis in a clinical setting (Castets et al. 1968;
Keating et al. 2005; Gehre, Otu et al. 2013). Since early bio-
chemical studies did not discern between different lineages of
M. africanum (Castets et al. 1968) and to our knowledge the
only systematic evaluation of M. africanum growth rate was
performed in L6 strains (Bold et al. 2012; Gehre, Otu et al.
2013), we investigated in vitro growth behavior of our L5
strain collection.
When handling the strains, we noticed a trend of slower
growth on solid media for L5.1 strains and therefore per-
formed in vitro growth curves in our standard M. africanum
culture medium. M. tuberculosis H37Rv clearly grew faster
than all M. africanum isolates (fig. 2). During exponential
growth, no lineage-, or sublineage-specific growth character-
istics could be observed. However, a sublineage-dependent
trend of different maximum optical densities was seen. While
L6 and L5.1 strains all reached a plateau of optical density
between OD600 1.35 and 1.50, all L5.2 strains reached a
lower plateau between OD600 1.06–1.28. The two L5 orphan
strains seemed to exhibit an intermediate phenotype. In par-
allel, we performed assessment of growth on solid 7H11 me-
dium, by serial dilution and spotting of 20ml of liquid cultures
at Day 1 of the growth curves. This confirmed a previous
observation by Bold et al. that a culture of M. africanum L6
of a given OD600 contains fewer CFU than that of the L4
isolate H37Rv, possibly because of larger bacterial size (Bold
et al. 2012) and extends this observation to all M. africanum
sublineages tested here (supplementary fig. 2, Supplementary
Material online). In contrast to the growth curve, this analysis
confirmed the observed slower growth phenotype of L5.1
compared with all other (sub)lineages (microcolonies appear-
ing after>20 days of culture). L6 and other L5 isolates grew at
similar rates (microcolonies appearing after 15 days culture)
while H37Rv clearly outgrew all M. africanum isolates (micro-
colonies after 12 days). This observation was confirmed and
quantified by counting the CFUs of all isolates after 17 and
24 days of culture (supplementary fig. 2, Supplementary
Material online). These results show that different sublineages
of M. africanum L5 have different growth characteristics
in vitro depending on the used culture medium.
Secretion analysis of M. africanum Unexpectedly Reveals
Fully Functional ESX-1 Secretion in L5
Type VII protein secretion by the secretion systems ESX-1
and ESX-5 are important virulence determinants for M. tu-
berculosis isolates, which can be affected by relatively small
polymorphisms (Gonzalo-Asensio et al. 2014; Ates,
Dippenaar et al. 2018). Recently, polymorphisms in the
PhoPR two component regulatory system were found to
impair virulence, by impacting espACD-mediated secretion
of ESX-1 proteins (Blasco et al. 2012; Gonzalo-Asensio et al.
2014; Lou et al. 2017). Since some of these mutations were
predicted to be present in M. africanum strains (Gonzalo-
Asensio et al. 2014; Malone and Gordon 2017) (supplemen-
tary file 2, Supplementary Material online), we analyzed
their occurrence in combination with a detailed phenotypic
Fig. 2—Sublineage-specific growth characteristics of M. africanum
sublineages. Precultures of the indicated strains were grown until midlo-
garithmic phase and were diluted to 0.05 OD600/ml in glass tubes con-
taining 5 ml of liquid 7H9 medium supplemented with 0.05% Tween 80,
ADC supplement and 0.2% pyruvate. Optical density was measured at the
indicated time points (symbols). Data points are averages of three individ-
ual experiments performed in technical duplicates. Colors of line indicate
the specific (sub)lineage ofM. tuberculosis (Mtb) or M. africanum (Maf) on
the legend (top left). Individual isolates can be identified by combination of
colors and symbols used (bottom right).
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protein expression and secretion analysis. Our analysis
showed that the PhoR V71I polymorphism was present in
all M. africanum strains of our collection (supplementary file
2, Supplementary Material online), while the deletion of
region RD8 (Orgeur and Brosch 2018) was only detected
in the L6 strains (supplementary fig. 1, Supplementary
Material online). Secretion of EsxA (also known as the
6 kDa early secretory antigenic target ESAT-6) was detected
in all M. africanum L5 isolates and occurred at comparable
levels to M. tuberculosis H37Rv, while the two M. africanum
L6-isolates secreted elevated levels of EsxA (fig. 3).
Interestingly, EsxA was detected efficiently in the whole-
cell lysates of all L5 and L6 isolates, but only scarcely in
H37Rv, probably because H37Rv is a relatively weak EsxA
producing strain due to the specific mutation in the pro-
moter region of whiB6 regulatory gene (Solans et al. 2014).
In conclusion, we found similar EsxA secretion in M. tuber-
culosis H37Rv and M. africanum L5, and relatively elevated
levels in L6 strains, whereby the latter phenomenon is likely
linked to the RD8 deletion.
A Sublineage Specific PE_PGRS Secretion Defect
Independent of PPE38
We previously showed that the ESX-5 substrate PPE38 is re-
quired for the secretion of two large subgroups of other ESX-
5 substrates called the PE_PGRS and PPE-MPTR proteins (Ates,
Dippenaar et al. 2018). Deletions of the ppe38-locus and con-
curring secretion defects increase virulence of M. tuberculosis
during late stage infection. The locus encoding ppe38 and its
highly similar copy ppe71, is highly variable in different M.
tuberculosis isolates due to frequent recombination/deletion
events and/or introduction of an IS6110 insertion element and
is part of the RD5 locus that is deleted in M. bovis, M. bovis
BCG, and several other animal adapted isolates (Brodin et al.
2002; Garnier et al. 2003; McEvoy et al. 2009; Ates,
Dippenaar et al. 2018; Ates, Sayes et al. 2018). Conflicting
results about the deletion of RD5 in M. africanum have been
reported varying between 0% and 45.4% of M. africanum
strains (Viana-Niero et al. 2001; Brosch et al. 2002; Gaudrat
et al. 2006). Genome analysis and PCR amplification of the
RD5-associated gene plcA (Brosch et al. 2002) and the ppe38-
71 locus revealed that only one L5 strain (77, L5.2) had RD5
deleted. Interestingly, all other L5 strains were found to have
only one copy of ppe38, while the L6 strains and H37Rv pos-
sessed the more common four-gene ppe38-71 locus (McEvoy
et al. 2009; Ates, Dippenaar et al. 2018; Ates, Sayes et al.
2018).
Based on the finding that only one strain was a natural
ppe38-deletion mutant, we hypothesized that only this strain
would be deficient in PE_PGRS secretion. Contrary to this
hypothesis, all lineage 5.2 strains exhibited a clear deficiency
in PE_PGRS secretion, while all other M. africanum strains
secreted these proteins (fig. 3). It should be noted that three
L5.2 isolates (76, NRC2, and NRC4), reproducibly secreted
residual amounts of PE_PGRS, which is unlike the phenotype
of M. tuberculosis ppe38-deleted strains (Ates, Dippenaar
et al. 2018). The pattern of both expressed (whole-cell lysate)
and secreted PE_PGRS proteins of L6 strains were clearly dis-
tinguishable from the other strains (fig. 3).
Furthermore, all M. africanum isolates secreted relatively
low levels of the ESX-5 substrate EsxN (fig. 3). This reduced
secretion coincided with accumulation of EsxN in the whole-
cell lysate of L6 strains as well as L5.1 and L5 orphan isolates,
Fig. 3—Secretion analysis of different M. africanum sublineages reveals functional EsxA secretion in L5 isolates and a PE_PGRS secretion defect in L5.2.
The phylogenomic relationship of the indicated isolates is depicted by the tree on top of the figure where red indicates L4, brown L5.1, blue orphan L5
isolates, purple L5.2 and green L6. Whole-cell lysates (Left) reveal similar expression levels of PE_PGRS proteins although the detected pattern is different in L6
isolates. EsxN is intracellularly accumulated in all M. africanum isolates except Lineage 5.2. Culture filtrates (right) reveal the L5.2 specific PE_PGRS secretion
defect and overall functional EsxA secretion, while EsxN secretion is lower in all M. africanum isolates compared with H37Rv. GroEL2 and SigA staining were
used as loading and lysis controls.
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but not in L5.2, where EsxN seemed to be expressed and
secreted only in isolate 68 (fig. 3).
Together, these data reveal a L5.2-specific PE_PGRS secre-
tion defect that is seemingly independent of the genetic pres-
ence of ppe38. Therefore, we investigated whether this
defect might be caused by a loss of transcription or translation
of ppe38. Closer investigation of the ppe38 gene locus in all
affected isolates (except the RD5-deleted isolate 77) revealed
a c ! a synonymous SNP corresponding at position 1026 of
the ppe38 gene in the L5.2 strains, but not in other M. afri-
canum isolates (supplementary file 2, sheet 2, Supplementary
Material online). This SNP results in a codon that is approxi-
mately four times less commonly utilized in M. tuberculosis
(codon occurrence per 1,000 in M. tuberculosis H37Rv coding
sequences: gcg ¼48.7 ! gcu 10.9. Source: http://www.
kazusa.or.jp/codon/). To test if reduced ppe38 transcription
or translation was a possible explanation for the PE_PGRS
secretion defect, we introduced an integrative plasmid that
constitutively expresses the ppe38-71 locus (mt2419-22) and
successfully complements PPE38-dependent secretion in L2,
L4, or BCG isolates, in two L5.2 strains, that is, isolate 68, with
functional EsxN secretion and in the RD5-deleted isolate 77
(Ates, Dippenaar et al. 2018; Ates, Sayes et al. 2018). Three
PCR-confirmed plasmid-containing clones were tested for
PE_PGRS secretion. Low levels of PE_PGRS secretion could
be observed in all complemented colonies, showing that
L5.2 strains have a PE_PGRS secretion defect, which seems
to be independent of ppe38 and may therefore help to un-
cover novel factors required for the secretion of these
proteins.
We set out to uncover such a novel factor by comparison
of our genome sequence of L5 orphan representatives and
L5.2 and identifying genomic variants specific for L5.2, which
may contribute to this PE_PGRS secretion defect. A compar-
ison of large sequence polymorphisms uncovered only one
deletion shared by all L5.2 strains, but none of the other M.
africanum strains. This polymorphism was a putative in-frame
deletion of 1,728 bp within the ppe-mptr gene ppe54.
Unfortunately, we were unable to confirm this deletion by
PCR, because of the highly repetitive nature and large size
of the gene. In parallel, 43 nonsynonymous SNPs or indels
were found to be shared between all L5.2 strains (isolate 77
was excluded for this analysis), but with no other M. africa-
num strains (supplementary file 2, sheet 3, Supplementary
Material online). None of these L5.2 specific variants were
located in the esx5 locus or could be directly linked to a
PE_PGRS secretion defect, although a number of variants
were found in ESX-5 substrates, which could be of future
interest.
Together, these results confirm that ESX-5 secretion can
be markedly different in closely related strains of M. africa-
num. Since EsxN secretion is clearly functional in strain 68,
the PE_PGRS secretion defect in L5.2 strains is no general
ESX-5 secretion defect and occurs in spite of a genetically
intact ppe38. Therefore additional mechanisms may be re-
quired for the secretion of PE_PGRS/PPE-MPTR proteins.
T-Cell Responses Against M. africanum Correlate With In
Vitro Secretion Analysis and Include Strong Responses
Against ESX-1-Dependent Substrates
Secretion of ESX Type VII secretion substrates is required for
the efficient induction of CD4þ T-cell responses (Majlessi et al.
2005; Brodin et al. 2006; Sayes et al. 2012; Ates, Sayes et al.
2018; Sayes et al. 2018). Since we were surprised by the
observed in vitro secretion phenotypes of L5 isolates, we set
out to assess how these characteristics affect the cellular im-
mune responses induced by strains belonging to different M.
africanum sublineages. We infected C57BL/6 CBA F1 mice
with M. tuberculosis H37Rv, or with M. africanum (sub)line-
age representatives of L6 (strain 01), L5.1 (strain 65), an L5
orphan isolate (strain 69), or Lineage 5.2 with (strain 77) or
without (strains 68) an RD5-like deletion. Three weeks post-
infection, mice were killed and splenocytes were stimulated
with previously identified immunogenic peptides. Interferon-c
(IFNc) production was measured as a readout of induced T-
cell-mediated immunogenicity (Sayes et al. 2012, 2018; Ates,
Sayes et al. 2018). Splenocytes from infected mice produced
similar patterns of IFN-c upon stimulation with immunogenic
peptides derived from the twin-arginine transporter substrate
FbpA (Ag85A241–260), ESX-1 substrates EsxA (EsxA1:20), EsxB
(both MHC-II-restricted EsxB11–25 and MHC-I-restricted
EsxB32–39), EspC (EspC40–54) and PPE68 (PPE68121–136), or
ESX-5 substrates PE19 (PE191–18, an epitope highly specific
to the esx-5 region) and PPE25 (PPE251–20, a shared epitope
by other PPE proteins encoded outside esx-5 region) (Sayes
et al. 2012, 2016) (fig. 4A; supplementary fig. 4,
Supplementary Material online). Only the splenocyte
responses to the two immunogenic peptides PPE10221–235
and PPE10381–395 derived from the ESX-5 dependent
PPE-MPTR protein PPE10 differed markedly between subli-
neages, with an approximately 90% reduction of IFN-c pro-
duction in splenocytes from mice immunized with L5.2
strains, compared with L4 reference H37Rv (fig. 4B; supple-
mentary fig. 4, Supplementary Material online). We previ-
ously showed that not only in vitro secretion, but also in vivo
induction of T-cell immunity against PPE10 is dependent on
PPE38 (Ates, Sayes et al. 2018). However, similar to the
observed in vitro PE_PGRS secretion phenotype, both L5.2
isolates were unable to induce immune responses to PPE10
even though isolate 68 does contain one copy of the ppe38
gene. This result suggests that the presumed PPE38-
independent PE_PGRS secretion defect of L5.2 isolate can
also be extended to the PPE-MPTR proteins. Sublineage L5.1
and L5 orphan representatives induced moderately reduced
IFN-c production in response to PPE10-peptides in compar-
ison to L4 and L6 isolates, possibly because these latter
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isolates possess a full-length ppe38-locus, while L5 strains
only have one copy of ppe38 and no esxXY genes.
Moreover, we found that M. africanum L5 and L6 isolates
were able to induce T-cell responses against selected ESX-1
dependent substrates, confirming the above reported results
on EsxA secretion under in vitro conditions. These results also
suggest that the previously reported mutation in phoR in M.
africanum might not have a strong impact on EsxA secretion
in the genomic background of L5 strains. Alternatively, L5
strains might carry yet unknown compensatory mutations
that limit the impact of the phoR mutation in these strains.
Discussion
In this work, we systematically compared genomic phylogeny
and phenotypic traits of M. africanum L5 isolated over
Fig. 4—Sublineage-specific differences in immunogenicity of M. africanum. (A) Two 6-week-old female C57BL/6 x CBA F1 (H-2b/k) mice per group
subcutaneously received 1106 CFU/mouse of the indicated mycobacterial strains. Three weeks later, mouse splenocytes were stimulated with peptides
containing known immunogenic MHC-II (closed bars) or MHC-I (open bars) restricted epitopes (listed on the y axes). IFN-c production of stimulated
splenocytes was measured as a readout of T-cell stimulation (x axes). The (sub)lineage of the tested strains is indicated in bold typeset in the top-right of
each panel. Colors indicate the nature of the tested immunogenic peptides. Green: twin-arginine transported substrate; blue: ESX-1 substrate; orange/pink
ESX-5 substrate; pink putative PPE38-dependent substrate; black: positive and negative controls. (B) Relative immunogenicity of ESX-5-secreted substrate
PPE10 in M. africanum compared with M. tuberculosis H37Rv (dotted line at 100%), reveals PPE-MPTR secretion defect in L5.2 isolates 68 and 77 (purple
bars), while other ESX-5 dependent substrates PE19 and PPE25, or the TAT-secreted substrate Ag85A were not significantly affected.
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multiple decades in France. In contrast to the high incidence
of these strains in their endemic region (de Jong et al. 2010),
L5-isolates are only rarely detected in France and are strongly
associated with patients born in countries endemic for L5
(Viana-Niero et al. 2001; de Jong et al. 2010; Sharma et al.
2016). This is emphasized by the finding that only seven L5
isolates were submitted to the French National Reference
Centre for tuberculosis between 2007 and 2016, while ap-
proximately 1,000 samples of M. tuberculosis/MTBC strains
are received each year. Furthermore, all these strains were
isolated from patients in different French cities and therefore
fully support the hypothesis that there is no direct transmis-
sion of M. africanum L5 in France and the transmission events
probably occurred in the countries of birth of the patients.
However, the finding that five out of the seven newly de-
scribed strains were isolated from extrapulmonary tissues
opens the question whether L5 strains are reduced in their
pathogenic potential once infection has been established. In
fact, it would be an interesting subject of further work to
assess whether this high rate of extrapulmonary tuberculosis
is truly associated with M. africanum L5 and if this may con-
tribute to the low levels of transmission. Although three of the
seven patients carrying L5 isolates were HIV positive, three
others were tested to be HIV-negative, suggesting that L5
strains can also multiply in immunocompetent hosts. An im-
portant clinical finding is the isolation of pre-XDR L5-isolate
NRC7, which was isolated from a patient who did not report
previous antituberculosis treatment, suggesting that this
strain was transmitted in its current pre-XDR form. MDR iso-
late NRC6 and pre-XDR isolate NRC7, which share identical
spoligotypes and very similar MIRU-VNTR profiles, were the
two most-recently isolated L5-isolates submitted to the NRC
and highlight that development of drug-resistance is not lim-
ited to M. tuberculosis L1–L4, but may also be increasing for
M. africanum L5 isolates. Finally, it is particularly intriguing
that all the multidrug-resistant strains belonged to sublineage
L5.2, suggesting these strains may transmit more efficiently or
develop drug-resistance more readily than their closely related
counterparts.
Although the isolation of these strains from France is an
interesting observation, these strains do not significantly con-
tribute to the French tuberculosis burden. However, the
strong geographical restriction of M. africanum and lack of
transmission within France, in spite of relatively severe symp-
toms associated with infection, is of significant fundamental
scientific interest to identify the factors that have contributed
to the global success of the so-called generalist (sub)lineages
of M. tuberculosis (Brites and Gagneux 2015; Stucki et al.
2016). Furthermore, the recent increase in availability of my-
cobacterial genomes allows for valuable meta-analyses about
general variation and adaptation of the MTBC (Comas et al.
2010; Copin et al. 2014; Brites and Gagneux 2015). However,
for such analyses to reach maximum potential it is important
to include strains reflecting the true diversity of the MTBC. In
this light, it is important to note that all previously published
L5 genomes were found to belong to sublineage 5.1 and that
therefore the genomic diversity of L5 has been underesti-
mated. We would like to suggest future phylogenomic and
meta-genomic studies to include at least one representative of
sublineage 5.2 and the genomes of orphan isolates 69 and
NRC1. The latter two strains were classified as orphan L5
representatives, despite of their previous classification as
A2–2 by Brudey et al. (2004), because of their reciprocal ge-
nomic distances from L5.1 as well as L5.2 strains. These iso-
lates may represent orphan members of two different
sublineages. The genomes of all these isolates are publicly
available (Accession number: PRJEB25506) and we have pro-
vided extensive supplementary analyses that may aid biolo-
gists in further pursuing the questions that have been raised
by our work (supplementary files 1–3, Supplementary
Material online).
A direct effect of the low amount of diversity in previously
analyzed L5 isolates is the use of RD711 as a genomic marker
to identify L5 isolates (Mostowy et al. 2004). It was suggested
previously, that this marker may not identify all L5 isolates
(Huard et al. 2006) and this is now confirmed by our finding
that this region is deleted in all L5.1 isolates, but not in other
L5 sublineages. Therefore, the SNP-polymorphisms proposed
by Vasconcellos et al., RD713, or RD743 may be better suited
as lineage-specific markers for L5 (Mostowy et al. 2004;
Huard et al. 2006; Vasconcellos et al. 2010). Hopefully, the
continuing increase in power and decrease in cost of sequenc-
ing techniques will make such typing techniques obsolete, but
they are currently still of importance for epidemiological stud-
ies in the countries where M. africanum is prevalent and
resources and facilities are relatively scarce. This is also true
for spoligotyping and MIRU-VNTR, methods which are more
informative from an epidemiological perspective than lineage-
specific polymorphisms. Spoligotyping has been the predom-
inant technique in the few studies examining the phylogeny
of L5 isolates (Viana-Niero et al. 2001; Brudey et al. 2004;
Gehre, Antonio et al. 2013). Of course, the resolution of
spoligotyping is inferior to that of the whole genome se-
quencing applied here. However, the combination of
whole-genome sequences with spoligotypes and MIRU-
VNTR patterns provided here (supplementary table 1, sheet
3, Supplementary Material online) or previously may increase
the resolution of newly performed analysis by providing a
robust phylogenetic framework (Viana-Niero et al. 2001;
Brudey et al. 2004). Retrospective analysis of the data sets
from Viana-Niero et al. and our study showed that of the
eleven L5.2 isolates, seven were associated with patients
from Cameroon and two with patients from the
Democratic Republic of Congo (the 2 remaining being of un-
known origin), but not with countries such as Ivory Coast,
Benin, Ghana and Nigeria, where L5 is also prevalent
(Viana-Niero et al. 2001; Brudey et al. 2004). Therefore,
L5.2 may be even more geographically restricted to the
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Central-African part of the L5-endemic area, compared with
the Western African countries, which could explain the scar-
city of these isolates in previous publications.
Having the genomes of the different sublineages available,
allows hypothesis-formation with respect to specific muta-
tions associated with predicted or observed phenotypic traits.
One such hypothesis was that L5 strains may secrete lower
levels of EsxA in comparison with L6 or L1–4 strains. This was
based on the previous finding that L5 strains share the phoR71
(GTT ! ATT) mutation that was shown to reduce ESX-1 se-
cretion, but do not have the RD8 deletion, which compen-
sates for this reduction by constitutive expression of the
EspACD proteins (Gonzalo-Asensio et al. 2014; Ates and
Brosch 2017). However, we were unable to provide evidence
for this hypothesis, since all L5 isolates secreted EsxA at levels
that were at least comparable to H37Rv and induced compa-
rable T-cell responses to different ESX-1-dependent secreted
antigens in vivo. It has to be mentioned, however, that M.
tuberculosis H37Rv expresses and secretes lower amounts of
EsxA than other M. tuberculosis strains (Solans et al. 2014).
Another possible explanation for this observation could be
that the L5 isolates have another yet unknown secondary
mutation to compensate for the reduction in EsxA secretion
caused by the phoR71 (GTT ! ATT) polymorphism, which is
not present in the M. tuberculosis genomic background. The
two L6 isolates secreted slightly, but reproducibly higher levels
of EsxA, which are likely to be caused by the deregulation of
the espACD locus linked to the RD8 deletion in these strains.
Finally, it should be mentioned that EsxA is only one of several
ESX-1 substrates and might not be solely responsible for the
PhoPR/ESX-1-associated virulence phenotype of tubercle ba-
cilli (Conrad et al. 2017), which also involves a wide range of
virulence lipids (Gonzalo-Asensio et al. 2014; Augenstreich
et al. 2017). Further work on the variation of the PhoPR sys-
tem and the associated secretion and virulence phenotypes in
the different lineages of tubercle bacilli will be of great
interest.
Perhaps one of the most striking phenotypic differences
between the different L5 sublineage was the PPE38-
independent PE_PGRS secretion defect of sublineage 5.2.
Since deletion of ppe38 and the associated PE_PGRS/PPE-
MPTR secretion defect were found to increase virulence of
M. tuberculosis L2 and L4 isolates, L5.2 isolates may have a
similar increased potential of transmission compared with the
other L5 isolates. This hypothesis would account for the find-
ing that (i) 67% (4/6) of the L5 isolates received at the French
National Reference Center between 2007 and 2015 belong
to sublineage 5.2, and (ii) all the resistant NRC isolates, in
particular one MDR and one pre-XDR, are L5.2 isolates.
However, a larger-scale epidemiological study in local West-
African setting would be required to verify this hypothesis.
Even though previously published work suggested that ap-
proximately half of all M. africanum strains may harbor
RD5-deletions (Viana-Niero et al. 2001), we only identified
one strain with such a deletion. Intriguingly, all other L5.2
strains also had a clear PE_PGRS secretion deficiency even
though they contain an intact ppe38 gene. Constitutive ex-
pression of ppe38 by introduction of the vector that was pre-
viously successfully used to complement L2, L4 and BCG
strains (Ates, Dippenaar et al. 2018; Ates, Sayes et al.
2018), did not restore the PE_PGRS secretion defect, suggest-
ing that this defect is PPE38-independent. Unfortunately, we
were unable to identify the genomic cause of this phenotype.
However, these results provide the basis to uncover such ad-
ditional factors in future work with the help of the here
reported genomes. Such insight might aid in understanding
the molecular mechanism by which PPE38 is required for the
secretion of PE_PGRS and PPE-MPTR proteins. Since deletion
of ppe38 and the associated PE_PGRS/PPE-MPTR secretion
defect were found to cause increase virulence in M. tubercu-
losis L2 and L4 isolates, it is tempting to speculate that the
PE_PGRS/PPE-MPTR secretion defect in L5.2 isolates is bal-
anced by another mutation that limits the increase in viru-
lence, since these isolates are also not transmitted outside
their endemic area. In this perspective it should be empha-
sized that many of the animal-adapted strains of the MTBC
have independent deletions of the RD5 region, leading to a
similar secretion defect (Ates, Sayes et al. 2018), which could
be suggestive of convergent evolution in these branches of
the MTBC.
Taken together, by sequencing 15 M. africanum L5 strains
isolated in France during the previous decades, we have un-
covered a surprisingly high level of genomic and phenotypic
diversity. Mycobacterium africanum L5 caused pulmonary
and/or extrapulmonary tuberculosis in both HIV-positive and
negative patients and we report a pre-XDR isolate from a
patient that was not previously treated. The reported genome
sequences of these isolates and their associated phenotypic
traits with respect to growth, secretion, and immunogenicity
may help to increase our understanding of the interesting L5
isolates of M. africanum, which are highly geographically re-
stricted. Understanding this geographic restriction may un-
cover the factors that have allowed other M. tuberculosis
lineages to spread worldwide.
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Supplementary data are available at Genome Biology and
Evolution online.
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